Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neuroscience Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Teva Pharmaceutical Industries
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
Eli Lilly and Company
F Hoffmann-La Roche Ltd
Biogen
Merck & Co, Inc
Novartis AG
UCB SA
AstraZeneca
Bayer AG
Pfizer
By Type:
Psychotic Disorders
Autism Spectrum Disorders
Epileptic Disorders
Alzheimer Disease
Anti-Parkinson's Drugs
Others
By Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neuroscience Drug Market Overview 2018-2029
-
1.1 China Neuroscience Drug Industry Development Overview
-
1.2 China Neuroscience Drug Industry Development History
-
1.3 China Neuroscience Drug Industry Market Size (2018-2029)
-
1.4 China Neuroscience Drug Market Analysis by Type from Production Side
-
1.4.1 China Neuroscience Drug Production Volume, Production Value and Growth Rate of Psychotic Disorders (2018-2029)
-
1.4.2 China Neuroscience Drug Production Volume, Production Value and Growth Rate of Autism Spectrum Disorders (2018-2029)
-
1.4.3 China Neuroscience Drug Production Volume, Production Value and Growth Rate of Epileptic Disorders (2018-2029)
-
1.4.4 China Neuroscience Drug Production Volume, Production Value and Growth Rate of Alzheimer Disease (2018-2029)
-
1.4.5 China Neuroscience Drug Production Volume, Production Value and Growth Rate of Anti-Parkinson's Drugs (2018-2029)
-
1.4.6 China Neuroscience Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Neuroscience Drug Market Analysis by Application from Consumption End
-
1.5.1 China Neuroscience Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.2 China Neuroscience Drug Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.3 China Neuroscience Drug Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.6 China Neuroscience Drug Market Analysis by Region
-
1.6.1 North China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neuroscience Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Neuroscience Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neuroscience Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neuroscience Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Neuroscience Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neuroscience Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neuroscience Drug Industry Development
Chapter 3 Neuroscience DrugIndustry Chain Analysis
-
3.1 Neuroscience Drug Industry Chain
-
3.2 Neuroscience Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neuroscience Drug Market
-
3.3 Neuroscience Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neuroscience Drug Market
Chapter 4 China Neuroscience Drug Market, by Type
-
4.1 China Neuroscience Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neuroscience Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Neuroscience Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Neuroscience Drug Production Volume and Growth Rate of Psychotic Disorders
-
4.5.2 China Neuroscience Drug Production Volume and Growth Rate of Autism Spectrum Disorders
-
4.5.3 China Neuroscience Drug Production Volume and Growth Rate of Epileptic Disorders
-
4.5.4 China Neuroscience Drug Production Volume and Growth Rate of Alzheimer Disease
-
4.5.5 China Neuroscience Drug Production Volume and Growth Rate of Anti-Parkinson's Drugs
-
4.5.6 China Neuroscience Drug Production Volume and Growth Rate of Others
Chapter 5 China Neuroscience Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neuroscience Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Neuroscience Drug Market Size and Growth Rate, by Application
-
5.5.1 China Neuroscience Drug Market Size and Growth Rate of Hospital Pharmacies
-
5.5.2 China Neuroscience Drug Market Size and Growth Rate of Retail Pharmacies
-
5.5.3 China Neuroscience Drug Market Size and Growth Rate of Online Pharmacies
Chapter 6 China Neuroscience Drug Market, by Region
-
6.1 China Neuroscience Drug Production Volume and Production Value, by Region
-
6.2 China Neuroscience Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Neuroscience Drug Market Analysis
-
7.1 North China Neuroscience Drug Market, by Type
-
7.2 North China Neuroscience Drug Market, by Application
Chapter 8 Central China Neuroscience Drug Market Analysis
-
8.1 Central China Neuroscience Drug Market, by Type
-
8.2 Central China Neuroscience Drug Market, by Application
Chapter 9 South China Neuroscience Drug Market Analysis
-
9.1 South China Neuroscience Drug Market, by Type
-
9.2 South China Neuroscience Drug Market, by Application
Chapter 10 East China Neuroscience Drug Market Analysis
-
10.1 East China Neuroscience Drug Market, by Type
-
10.2 East China Neuroscience Drug Market, by Application
Chapter 11 Northeast China Neuroscience Drug Market Analysis
-
11.1 Northeast China Neuroscience Drug Market, by Type
-
11.2 Northeast China Neuroscience Drug Market, by Application
Chapter 12 Southwest China Neuroscience Drug Market Analysis
-
12.1 Southwest China Neuroscience Drug Market, by Type
-
12.2 Southwest China Neuroscience Drug Market, by Application
Chapter 13 Northwest China Neuroscience Drug Market Analysis
-
13.1 Northwest China Neuroscience Drug Market, by Type
-
13.2 Northwest China Neuroscience Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Teva Pharmaceutical Industries
-
14.1.1 Teva Pharmaceutical Industries Company Profile
-
14.1.2 Teva Pharmaceutical Industries Neuroscience Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Boehringer Ingelheim GmbH
-
14.2.1 Boehringer Ingelheim GmbH Company Profile
-
14.2.2 Boehringer Ingelheim GmbH Neuroscience Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 GlaxoSmithKline plc
-
14.3.1 GlaxoSmithKline plc Company Profile
-
14.3.2 GlaxoSmithKline plc Neuroscience Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Eli Lilly and Company
-
14.4.1 Eli Lilly and Company Company Profile
-
14.4.2 Eli Lilly and Company Neuroscience Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 F Hoffmann-La Roche Ltd
-
14.5.1 F Hoffmann-La Roche Ltd Company Profile
-
14.5.2 F Hoffmann-La Roche Ltd Neuroscience Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Biogen
-
14.6.1 Biogen Company Profile
-
14.6.2 Biogen Neuroscience Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Merck & Co, Inc
-
14.7.1 Merck & Co, Inc Company Profile
-
14.7.2 Merck & Co, Inc Neuroscience Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Novartis AG
-
14.8.1 Novartis AG Company Profile
-
14.8.2 Novartis AG Neuroscience Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 UCB SA
-
14.9.1 UCB SA Company Profile
-
14.9.2 UCB SA Neuroscience Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 AstraZeneca
-
14.10.1 AstraZeneca Company Profile
-
14.10.2 AstraZeneca Neuroscience Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Bayer AG
-
14.11.1 Bayer AG Company Profile
-
14.11.2 Bayer AG Neuroscience Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Pfizer
-
14.12.1 Pfizer Company Profile
-
14.12.2 Pfizer Neuroscience Drug Market Performance
-
14.12.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neuroscience Drug Industry Research Conclusions
-
15.2 Neuroscience Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neuroscience Drug Industry Market Size (2018-2029)
-
Figure China Neuroscience Drug Production Volume, Production Value and Growth Rate of Psychotic Disorders (2018-2029)
-
Figure China Neuroscience Drug Production Volume, Production Value and Growth Rate of Autism Spectrum Disorders (2018-2029)
-
Figure China Neuroscience Drug Production Volume, Production Value and Growth Rate of Epileptic Disorders (2018-2029)
-
Figure China Neuroscience Drug Production Volume, Production Value and Growth Rate of Alzheimer Disease (2018-2029)
-
Figure China Neuroscience Drug Production Volume, Production Value and Growth Rate of Anti-Parkinson's Drugs (2018-2029)
-
Figure China Neuroscience Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Neuroscience Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Neuroscience Drug Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China Neuroscience Drug Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure North China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neuroscience Drug Market Size and Growth Rate from 2018-2029
-
Figure Neuroscience Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neuroscience Drug Market Share by Type in 2018
-
Figure China Neuroscience Drug Market Share by Type in 2023
-
Figure China Neuroscience Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neuroscience Drug Production Volume and Growth Rate of Psychotic Disorders (2018-2023)
-
Figure China Neuroscience Drug Production Volume and Growth Rate of Autism Spectrum Disorders (2018-2023)
-
Figure China Neuroscience Drug Production Volume and Growth Rate of Epileptic Disorders (2018-2023)
-
Figure China Neuroscience Drug Production Volume and Growth Rate of Alzheimer Disease (2018-2023)
-
Figure China Neuroscience Drug Production Volume and Growth Rate of Anti-Parkinson's Drugs (2018-2023)
-
Figure China Neuroscience Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Neuroscience Drug Market Share by Application in 2018
-
Figure China Neuroscience Drug Market Share by Application in 2023
-
Figure China Neuroscience Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Neuroscience Drug Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Neuroscience Drug Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China Neuroscience Drug Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Table China Neuroscience Drug Production Volume by Region (2018-2023)
-
Table China Neuroscience Drug Production Volume Share by Region (2018-2023)
-
Figure China Neuroscience Drug Production Volume Share by Region (2018-2023)
-
Table China Neuroscience Drug Production Value by Region (2018-2023)
-
Table China Neuroscience Drug Production Value Share by Region (2018-2023)
-
Figure China Neuroscience Drug Production Value Share by Region (2018-2023)
-
Table China Neuroscience Drug Sales Volume by Region (2018-2023)
-
Table China Neuroscience Drug Sales Volume Share by Region (2018-2023)
-
Figure China Neuroscience Drug Sales Volume Share by Region (2018-2023)
-
Table China Neuroscience Drug Sales Value by Region (2018-2023)
-
Table China Neuroscience Drug Sales Value Share by Region (2018-2023)
-
Figure China Neuroscience Drug Sales Value Share by Region (2018-2023)
-
Table North China Neuroscience Drug Production Volume by Type (2018-2023)
-
Table North China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Figure North China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Table North China Neuroscience Drug Sales Volume by Application (2018-2023)
-
Table North China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Neuroscience Drug Production Volume by Type (2018-2023)
-
Table Central China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Table Central China Neuroscience Drug Sales Volume by Application (2018-2023)
-
Table Central China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Table South China Neuroscience Drug Production Volume by Type (2018-2023)
-
Table South China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Figure South China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Table South China Neuroscience Drug Sales Volume by Application (2018-2023)
-
Table South China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Table East China Neuroscience Drug Production Volume by Type (2018-2023)
-
Table East China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Figure East China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Table East China Neuroscience Drug Sales Volume by Application (2018-2023)
-
Table East China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neuroscience Drug Production Volume by Type (2018-2023)
-
Table Northeast China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Neuroscience Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neuroscience Drug Production Volume by Type (2018-2023)
-
Table Southwest China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Neuroscience Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neuroscience Drug Production Volume by Type (2018-2023)
-
Table Northwest China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neuroscience Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Neuroscience Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neuroscience Drug Sales Volume Share by Application (2018-2023)
-
Table Teva Pharmaceutical Industries Company Profile
-
Table Teva Pharmaceutical Industries Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim GmbH Company Profile
-
Table Boehringer Ingelheim GmbH Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table Biogen Company Profile
-
Table Biogen Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table Merck & Co, Inc Company Profile
-
Table Merck & Co, Inc Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table UCB SA Company Profile
-
Table UCB SA Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Neuroscience Drug Revenue, Price and Gross (2018-2023)
-
